COMPASS Pathways Management
Management criteria checks 2/4
COMPASS Pathways' CEO is Kabir Nath, appointed in Aug 2022, has a tenure of 3.25 years. total yearly compensation is $4.34M, comprised of 14.5% salary and 85.5% bonuses, including company stock and options. directly owns 0.047% of the company’s shares, worth MX$4.45M. The average tenure of the management team and the board of directors is 3.3 years and 5 years respectively.
Key information
Kabir Nath
Chief executive officer
US$4.3m
Total compensation
| CEO salary percentage | 14.48% |
| CEO tenure | 3.3yrs |
| CEO ownership | 0.05% |
| Management average tenure | 3.3yrs |
| Board average tenure | 5yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2025 | n/a | n/a | -US$237m |
| Jun 30 2025 | n/a | n/a | -US$138m |
| Mar 31 2025 | n/a | n/a | -US$138m |
| Dec 31 2024 | US$4m | US$628k | -US$155m |
| Sep 30 2024 | n/a | n/a | -US$144m |
| Jun 30 2024 | n/a | n/a | -US$139m |
| Mar 31 2024 | n/a | n/a | -US$129m |
| Dec 31 2023 | US$3m | US$595k | -US$118m |
| Sep 30 2023 | n/a | n/a | -US$117m |
| Jun 30 2023 | n/a | n/a | -US$102m |
| Mar 31 2023 | n/a | n/a | -US$95m |
| Dec 31 2022 | US$8m | US$243k | -US$92m |
Compensation vs Market: Kabir's total compensation ($USD4.34M) is above average for companies of similar size in the MX market ($USD277.04K).
Compensation vs Earnings: Kabir's compensation has increased whilst the company is unprofitable.
CEO
Kabir Nath (61 yo)
Mr. Kabir Kumar Nath M. A., M. B.A., is Chief Executive Officer and Director of COMPASS Pathways plc from August 1, 2022. He serves as President & CEO at Otsuka America Pharmaceutical, Inc. He served as Pr...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 3.3yrs | US$4.34m | 0.047% MX$ 4.5m | |
| CFO, Principal Financial Officer & Principal Accounting Officer | 1.7yrs | US$2.43m | 0.012% MX$ 1.1m | |
| Chief Medical Officer | 4.3yrs | US$1.48m | 0.0042% MX$ 393.9k | |
| Chief Technology Officer | 3.8yrs | no data | no data | |
| Senior Vice President of Investor Relations | no data | no data | no data | |
| Chief People Officer | no data | no data | no data | |
| Senior Advisor | 3.8yrs | no data | no data | |
| Advisor | no data | no data | no data | |
| Chief Research & Development Officer | 1.5yrs | no data | no data | |
| Chief Commercial Officer | 1.3yrs | no data | no data | |
| Chief Patient Officer | less than a year | no data | no data | |
| Company Secretary | 4.6yrs | no data | no data |
Experienced Management: CMPS N's management team is considered experienced (3.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 3.3yrs | US$4.34m | 0.047% MX$ 4.5m | |
| Member of Scientific Advisory Network | no data | no data | no data | |
| Independent Chairman | 1.2yrs | US$410.44k | 0% MX$ 0 | |
| Independent Director | 7.5yrs | US$411.56k | 0.039% MX$ 3.7m | |
| Independent Director | 2.2yrs | US$277.54k | 0% MX$ 0 | |
| Independent Non Executive Director | 5.3yrs | US$282.79k | 0% MX$ 0 | |
| Independent Non-Executive Director | 4.7yrs | US$276.79k | 0% MX$ 0 | |
| Independent Non-Executive Director | 7.5yrs | US$271.79k | 0.093% MX$ 8.8m | |
| Independent Non-Executive Director | 7.5yrs | US$290.28k | 0.038% MX$ 3.6m | |
| Member of Scientific Advisory Network | no data | no data | no data | |
| Member of Scientific Advisory Network | no data | no data | no data | |
| Special Advisor of Patient Experience | no data | no data | no data |
Experienced Board: CMPS N's board of directors are considered experienced (5 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/19 12:28 |
| End of Day Share Price | 2025/11/07 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
COMPASS Pathways plc is covered by 17 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Thomas Shrader | BTIG |
| Sumant Satchidanand Kulkarni | Canaccord Genuity |
| Charles Duncan | Cantor Fitzgerald & Co. |